Explore more publications!
Health Monitor Liechtenstein
Got News to Share?

Health Monitor Liechtenstein: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monitor Liechtenstein.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 24, 2025

Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference
November 24, 2025

Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference

Indeterminate GlobeNewswire
YD Bio Limited Announces U.S. Ophthalmology Market Entry, Advances Across Diagnostics and LSC Exosome Therapeutics
November 24, 2025

YD Bio Limited Announces U.S. Ophthalmology Market Entry, Advances Across Diagnostics and LSC Exosome Therapeutics

Indeterminate GlobeNewswire
Capricor Therapeutics Presents New Data Demonstrating a Scalable Framework for Loading Therapeutic Oligonucleotides into Exosomes at AAEV 2025
November 24, 2025

Capricor Therapeutics Presents New Data Demonstrating a Scalable Framework for Loading Therapeutic Oligonucleotides into Exosomes at AAEV 2025

Indeterminate GlobeNewswire
JenaValve Announces New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves
November 24, 2025

JenaValve Announces New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves

Indeterminate GlobeNewswire
FibroBiologics Announces $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 24, 2025

FibroBiologics Announces $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Indeterminate GlobeNewswire
OneMedNet to Showcase Transformative New Platform at RSNA 2025
November 24, 2025

OneMedNet to Showcase Transformative New Platform at RSNA 2025

Indeterminate GlobeNewswire
Clearmind Medicine's Data and Safety Monitoring Board Unanimously Approves Continuation of Phase I/IIa Clinical Trial for CMND-100 Following Positive Interim Safety Review
November 24, 2025

Clearmind Medicine's Data and Safety Monitoring Board Unanimously Approves Continuation of Phase I/IIa Clinical Trial for CMND-100 Following Positive Interim Safety Review

Indeterminate GlobeNewswire
Pharmaceutical Packaging Market worth $364.11 billion by 2030 at 15.8%, says MarketsandMarkets™
November 24, 2025

Pharmaceutical Packaging Market worth $364.11 billion by 2030 at 15.8%, says MarketsandMarkets™

Indeterminate GlobeNewswire
CytoDyn to Present Prolonged Survival Data on Leronlimab in Metastatic Triple-Negative Breast Cancer at the San Antonio Breast Cancer Symposium
November 24, 2025

CytoDyn to Present Prolonged Survival Data on Leronlimab in Metastatic Triple-Negative Breast Cancer at the San Antonio Breast Cancer Symposium

Indeterminate GlobeNewswire
Biotech Valuations Rise as New Clinical Platforms Show Progress
November 24, 2025

Biotech Valuations Rise as New Clinical Platforms Show Progress

Indeterminate GlobeNewswire
Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform
November 24, 2025

Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform

Indeterminate GlobeNewswire
Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition
November 24, 2025

Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition

Indeterminate GlobeNewswire
Jyong Biotech Ltd. Signs Non‑Binding Letter of Intent with Leading South Korean Pharmaceutical Company to Evaluate In‑Licensing of Plant-Derived MCS Drugs
November 24, 2025

Jyong Biotech Ltd. Signs Non‑Binding Letter of Intent with Leading South Korean Pharmaceutical Company to Evaluate In‑Licensing of Plant-Derived MCS Drugs

Indeterminate GlobeNewswire
Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025
November 24, 2025

Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025

Indeterminate GlobeNewswire
BioCardia Strengthens Leadership Team with The Addition of Farhan Shahab as Vice President of Quality
November 24, 2025

BioCardia Strengthens Leadership Team with The Addition of Farhan Shahab as Vice President of Quality

Indeterminate GlobeNewswire
Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
November 24, 2025

Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference

Indeterminate GlobeNewswire
LB Pharmaceuticals Announces Presentation at the Piper Sandler 37th Annual Healthcare Conference
November 24, 2025

LB Pharmaceuticals Announces Presentation at the Piper Sandler 37th Annual Healthcare Conference

Indeterminate GlobeNewswire
Cerevance to Highlight Potential of Solengepras in Parkinson’s Disease at the 2025 Parkinson Study Group Annual Meeting
November 24, 2025

Cerevance to Highlight Potential of Solengepras in Parkinson’s Disease at the 2025 Parkinson Study Group Annual Meeting

Indeterminate GlobeNewswire
Cidara Therapeutics Reaches Target Enrollment of Phase 3 ANCHOR Trial Evaluating CD388 for Prevention of Seasonal Influenza in High-Risk Populations
November 24, 2025

Cidara Therapeutics Reaches Target Enrollment of Phase 3 ANCHOR Trial Evaluating CD388 for Prevention of Seasonal Influenza in High-Risk Populations

Indeterminate GlobeNewswire
Daré Bioscience Receives $3.6 Million in Additional Grant Funding
November 24, 2025

Daré Bioscience Receives $3.6 Million in Additional Grant Funding

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions